3SBio saw the highest growth of 0.99% in patent filings in May and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.66% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of 3SBio’s patent filings and grants. Buy the databook here.
3SBio has been focused on protecting inventions in China(CN) with two publications in Q2 2024
The China(CN) Patent Office dominates the patent filings with nearly 50% of filings. The China(CN), European Patent Office(EPO), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where 3SBio is filings its patents..
Roche and Johnson & Johnson could be the strongest competitors for 3SBio
For comprehensive analysis of 3SBio's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.